Radiopharm Theranostics

RADXNasdaq Australia Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$40.257 M

$2.80 +0.36%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#360Hyperion DefiHYPD$40.9M
#361Nasus PharmaNSRX$40.5M
#362Radiopharm TheranosticsRADX$40.3M
#363CervoMedCRVO$38.8M
#364Incannex HealthcareIXHL$37.7M

Where these numbers come from

Share counts and financials for Radiopharm Theranostics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.